11-2169758-CA-C
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000360.4(TH):c.203delT(p.Leu68fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000548 in 1,460,062 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 34)
Exomes 𝑓: 0.0000055 ( 0 hom. )
Consequence
TH
NM_000360.4 frameshift
NM_000360.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.659
Genes affected
TH (HGNC:11782): (tyrosine hydroxylase) The protein encoded by this gene is involved in the conversion of tyrosine to dopamine. It is the rate-limiting enzyme in the synthesis of catecholamines, hence plays a key role in the physiology of adrenergic neurons. Mutations in this gene have been associated with autosomal recessive Segawa syndrome. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 11-2169758-CA-C is Pathogenic according to our data. Variant chr11-2169758-CA-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 557613.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TH | NM_000360.4 | c.203delT | p.Leu68fs | frameshift_variant | 2/13 | ENST00000352909.8 | NP_000351.2 | |
TH | NM_199292.3 | c.296delT | p.Leu99fs | frameshift_variant | 3/14 | NP_954986.2 | ||
TH | NM_199293.3 | c.284delT | p.Leu95fs | frameshift_variant | 3/14 | NP_954987.2 | ||
TH | XM_011520335.3 | c.215delT | p.Leu72fs | frameshift_variant | 2/13 | XP_011518637.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TH | ENST00000352909.8 | c.203delT | p.Leu68fs | frameshift_variant | 2/13 | 1 | NM_000360.4 | ENSP00000325951.4 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD3 genomes
Cov.:
34
GnomAD4 exome AF: 0.00000548 AC: 8AN: 1460062Hom.: 0 Cov.: 37 AF XY: 0.00000551 AC XY: 4AN XY: 726288
GnomAD4 exome
AF:
AC:
8
AN:
1460062
Hom.:
Cov.:
37
AF XY:
AC XY:
4
AN XY:
726288
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 34
GnomAD4 genome
Cov.:
34
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Autosomal recessive DOPA responsive dystonia Pathogenic:5
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Sep 05, 2023 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Apr 04, 2018 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 12, 2023 | Variant summary: TH c.296delT (p.Leu99ArgfsX15) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 245908 control chromosomes (gnomAD). c.296delT has been reported in the literature in at least one compound heterozygous individual affected with Segawa Syndrome, Autosomal Recessive (Furukawa_2001). The variant was also found occuring in a heterozygous adult with late-onset Dopa-responsive Dystonia (Bally_2020). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three ClinVar submitters have assessed the variant since 2014: one classified the variant as likely pathogenic and two as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Dec 01, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 08, 2023 | This sequence change creates a premature translational stop signal (p.Leu99Argfs*15) in the TH gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TH are known to be pathogenic (PMID: 22264700, 24753243). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with TH deficiency (PMID: 11160968, 12891655). ClinVar contains an entry for this variant (Variation ID: 557613). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at